Sagimet Biosciences Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sagimet Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2022 to Q3 2024.
  • Sagimet Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.55M, a 16.7% decline year-over-year.
  • Sagimet Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $5.07M.
  • Sagimet Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.99M, a 165% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.07M $1.55M -$309K -16.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.37M $1.45M +$392K +37.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $4.98M $759K -$8K -1.04% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.99M $1.31M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $1.86M +$1.47M +377% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.06M +$674K +176% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $767K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $389K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $383K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.